← Leaderboards
Paul O Schwarzenberger
Tulane University Of Louisiana
$3,319,899
Attributed
$3,319,899
Total exposure
17
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $725.8K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$3,319,899 · 17
By mechanism
U10$1,714,927 · 2
R01$1,367,343 · 1
M01$166,155 · 13
R03$71,474 · 1
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Richard A Oberhelman$11,866,170
- Paul Muntner$9,260,804
- Rudy M Ortiz$3,922,550
- Lydia Bazzano$16,911,507
- Jiang He$53,644,406
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectHuman Therapy EvaluationNeoplasm /Cancer ChemotherapyCombination Cancer TherapyTissue /Cell CultureEnzyme Linked Immunosorbent AssayInterleukin 6Helper T LymphocyteLaboratory MouseColony Stimulating FactorGene TherapyCytokine ReceptorsRecombinant VirusCytokineHematopoiesisMelanomaClinical Trial Phase IFlow CytometryGenetically Modified AnimalsGene TargetingPolymerase Chain ReactionNeoplasm /Cancer Radiation TherapyCytotoxic T Lymphocyte
Grant awards (32)
The Gulf Coast MBCCOP$400,000
U10 · FY2007 · CA · contact PI
Gulf Coast MBCCOP$98,932
U10 · FY2007 · CA · contact PI
Gulf Coast MBCCOP$391,381
U10 · FY2006 · CA · contact PI
IL-17 and Hematopoiesis$258,773
R01 · FY2006 · CA · contact PI
IL-17 and Hematopoiesis$50,000
R01 · FY2006 · CA · contact PI
INVESTIGATION OF CROSS IMMUNITY FOLLOWING VACCINATION WITH ALLOGENIC CANCER CELL$19,817
M01 · FY2006 · RR · contact PI
COMBINATION OF WEEKLY CHEST RADIOTHERAPY AND ORAL NAVELBINE FOR NSCLC$3,691
M01 · FY2006 · RR · contact PI
TREATMENT PROTOCOL FOR ALLOVECTIN-7 IN METASTATIC CANCER BY DIRECT GENE TRANSFER$1,943
M01 · FY2006 · RR · contact PI
COMBINATION OF WEEKLY RADIATION AND DOCETAXEL FOR LOCALLY ADVANCED NON SMALL CA$194
M01 · FY2006 · RR · contact PI
Gulf Coast MBCCOP$365,351
U10 · FY2005 · CA
IL-17 and Hematopoiesis$248,917
R01 · FY2005 · CA
COMBINATION OF WEEKLY CHEST RADIOTHERAPY AND ORAL NAVELBINE FOR NSCLC$52,950
M01 · FY2005 · RR
INVESTIGATION OF CROSS IMMUNITY FOLLOWING VACCINATION WITH ALLOGENIC CANCER CELL$28,102
M01 · FY2005 · RR
TREATMENT PROTOCOL FOR ALLOVECTIN-7 IN METASTATIC CANCER BY DIRECT GENE TRANSFER$5,029
M01 · FY2005 · RR
COMBINATION OF WEEKLY RADIATION AND DOCETAXEL FOR LOCALLY ADVANCED NON SMALL CA$2,071
M01 · FY2005 · RR
IL-17 and Hematopoiesis$177,500
R01 · FY2004 · CA
Combination of Weekly Radiation and Docetaxel for Locally Advanced Non Small Ca$26,333
M01 · FY2004 · RR
Combination of Weekly Chest Radiotherapy &Oral Navelbine$14,845
M01 · FY2004 · RR
MINORITY BASED COMMUNITY CLINICAL ONCOLOGY PROGRAM$459,263
U10 · FY2003 · CA
IL-17 and Hematopoiesis$177,500
R01 · FY2003 · CA
IL-17 and Hematopoiesis$177,500
R01 · FY2002 · CA
IL-17 AND HEMATOPOIESIS$139,863
R01 · FY2001 · CA
GENE TRANSFER OF HLA-B7 IN MELANOMA$0
M01 · FY2001 · RR
DACARBAZINE/ALLOVECTIN-7 IN METASTATIC MELANOMA$0
M01 · FY2001 · RR
RADIATION AND DOXETAXEL FOR NSCLC$0
M01 · FY2001 · RR
TREATMENT OF MALIGNANT PLEURAL MESOTHELIOMA W/ GENE MODIFIED CANCER CELL LINES$0
M01 · FY2001 · RR
IL-17 AND HEMATOPOIESIS$137,290
R01 · FY2000 · CA
TRIAL OF BRYOSTATIN/IL-2 TO ENHANCE ANTIGEN PRESENTATION$71,474
R03 · FY2000 · CA
TREATMENT OF MALIGNANT PLEURAL MESOTHELIOMA W/ GENE MODIFIED CANCER CELL LINES$11,180
M01 · FY2000 · RR
DACARBAZINE/ALLOVECTIN-7 IN METASTATIC MELANOMA$0
M01 · FY2000 · RR
RADIATION AND DOXETAXEL FOR NSCLC$0
M01 · FY2000 · RR
GENE TRANSFER OF HLA-B7 IN MELANOMA$0
M01 · FY2000 · RR